Opposing Roles of Dnmt1 in Early- and Late-Stage Murine Prostate Cancer

REFERENCES

• Baba, S., Y. Yamada, Y. Hatano, Y. Miyazaki, H. Mori, T. Shibata, and A. Hara. 2009. Global DNA hypomethylation suppresses squamous carcinogenesis in the tongue and esophagus. Cancer Sci. 100:1186–1191.
   PubMedGoogle Scholar
• Camoriano, M., S. R. Kinney, M. T. Moser, B. A. Foster, J. L. Mohler, D. L. Trump, A. R. Karpf, and D. J. Smiraglia. 2008. Phenotype-specific CpG island methylation events in a murine model of prostate cancer. Cancer Res. 68:4173–4182.
   PubMedGoogle Scholar
• Cooper, C. S., and C. S. Foster. 2009. Concepts of epigenetics in prostate cancer development. Br. J. Cancer 100:240–245.
   PubMed Web of Science ®Google Scholar
• Dehm, S. M., and D. J. Tindall. 2007. Androgen receptor structural and functional elements: role and regulation in prostate cancer. Mol. Endocrinol. 21:2855–2863.
   PubMed Web of Science ®Google Scholar
• Deng, T., Y. Kuang, L. Wang, J. Li, Z. Wang, and J. Fei. 2009. An essential role for DNA methyltransferase 3a in melanoma tumorigenesis. Biochem. Biophys. Res. Commun. 387:611–616.
   PubMedGoogle Scholar
• De Smet, C., C. Lurquin, B. Lethe, V. Martelange, and T. Boon. 1999. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol. Cell. Biol. 19:7327–7335.
   PubMed Web of Science ®Google Scholar
• Eads, C. A., A. E. Nickel, and P. W. Laird. 2002. Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in ApcMin/+ Dnmt1-hypomorphic Mice. Cancer Res. 62:1296–1299.
   PubMed Web of Science ®Google Scholar
• Eccles, S. A., and D. R. Welch. 2007. Metastasis: recent discoveries and novel treatment strategies. Lancet 369:1742–1757.
   PubMed Web of Science ®Google Scholar
• Eden, A., F. Gaudet, A. Waghmare, and R. Jaenisch. 2003. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300:455.
   PubMed Web of Science ®Google Scholar
• Ehrich, M., M. R. Nelson, P. Stanssens, M. Zabeau, T. Liloglou, G. Xinarianos, C. R. Cantor, J. K. Field, and D. van den Boom. 2005. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc. Natl. Acad. Sci. U. S. A. 102:15785–15790.
   PubMed Web of Science ®Google Scholar
• Esteve, P. O., H. G. Chin, A. Smallwood, G. R. Feehery, O. Gangisetty, A. R. Karpf, M. F. Carey, and S. Pradhan. 2006. Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev. 20:3089–3103.
   PubMed Web of Science ®Google Scholar
• Feinberg, A. P., and B. Tycko. 2004. The history of cancer epigenetics. Nat. Rev. Cancer 4:143–153.
   PubMed Web of Science ®Google Scholar
• Foley, C. L., and M. R. Feneley. 2009. The clinical significance and therapeutic implications of extraprostatic invasion. Surg. Oncol. 18:203–212.
   PubMedGoogle Scholar
• Gaudet, F., J. G. Hodgson, A. Eden, L. Jackson-Grusby, J. Dausman, J. W. Gray, H. Leonhardt, and R. Jaenisch. 2003. Induction of tumors in mice by genomic hypomethylation. Science 300:489–492.
   PubMed Web of Science ®Google Scholar
• Gingrich, J. R., R. J. Barrios, R. A. Morton, B. F. Boyce, F. J. DeMayo, M. J. Finegold, R. Angelopoulou, J. M. Rosen, and N. M. Greenberg. 1996. Metastatic prostate cancer in a transgenic mouse. Cancer Res. 56:4096–4102.
   PubMed Web of Science ®Google Scholar
• Greenberg, N. M., F. DeMayo, M. J. Finegold, D. Medina, W. D. Tilley, J. O. Aspinall, G. R. Cunha, A. A. Donjacour, R. J. Matusik, and J. M. Rosen. 1995. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. U. S. A. 92:3439–3443.
   PubMed Web of Science ®Google Scholar
• Guo, Z. S., J. A. Hong, K. R. Irvine, G. A. Chen, P. J. Spiess, Y. Liu, G. Zeng, J. R. Wunderlich, D. M. Nguyen, N. P. Restifo, and D. S. Schrump. 2006. De novo induction of a cancer/testis antigen by 5-aza-2′-deoxycytidine augments adoptive immunotherapy in a murine tumor model. Cancer Res. 66:1105–1113.
   PubMed Web of Science ®Google Scholar
• Hurwitz, A. A., B. A. Foster, J. P. Allison, N. M. Greenberg, and E. D. Kwon. 2001. The TRAMP mouse as a model for prostate cancer. Curr. Protoc. Immunol.Chapter20:Unit 20.5.
   Google Scholar
• Jair, K. W., K. E. Bachman, H. Suzuki, A. H. Ting, I. Rhee, R. W. Yen, S. B. Baylin, and K. E. Schuebel. 2006. De novo CpG island methylation in human cancer cells. Cancer Res. 66:682–692.
   PubMed Web of Science ®Google Scholar
• Kaplan-Lefko, P. J., T. M. Chen, M. M. Ittmann, R. J. Barrios, G. E. Ayala, W. J. Huss, L. A. Maddison, B. A. Foster, and N. M. Greenberg. 2003. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 55:219–237.
   PubMed Web of Science ®Google Scholar
• Karpf, A. R., and D. A. Jones. 2002. Reactivating the expression of methylation silenced genes in human cancer. Oncogene 21:5496–5503.
   PubMed Web of Science ®Google Scholar
• Karpf, A. R., and S. Matsui. 2005. Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. Cancer Res. 65:8635–8639.
   PubMed Web of Science ®Google Scholar
• Karpf, A. R., B. C. Moore, T. O. Ririe, and D. A. Jones. 2001. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2′-deoxycytidine. Mol. Pharmacol. 59:751–757.
   PubMed Web of Science ®Google Scholar
• Khulan, B., R. F. Thompson, K. Ye, M. J. Fazzari, M. Suzuki, E. Stasiek, M. E. Figueroa, J. L. Glass, Q. Chen, C. Montagna, E. Hatchwell, R. R. Selzer, T. A. Richmond, R. D. Green, A. Melnick, and J. M. Greally. 2006. Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res. 16:1046–1055.
   PubMed Web of Science ®Google Scholar
• Kim, E. K., J. Y. Kang, Y. H. Rho, Y. S. Kim, D. S. Kim, and Y. S. Bae. 2009. Silencing of the CKIIα and CKIIα′ genes during cellular senescence is mediated by DNA methylation. Gene 431:55–60.
   PubMedGoogle Scholar
• Kincl, F. A., M. Maqueo, and R. I. Dorfman. 1965. Influence of various steroids on testes and accessory sex organs in the rat. Acta Endocrinol. 49:145–154.
   PubMedGoogle Scholar
• Laird, P. W., L. Jackson-Grusby, A. Fazeli, S. L. Dickinson, W. E. Jung, E. Li, R. A. Weinberg, and R. Jaenisch. 1995. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81:197–205.
   PubMed Web of Science ®Google Scholar
• La Salle, S., C. Mertineit, T. Taketo, P. B. Moens, T. H. Bestor, and J. M. Trasler. 2004. Windows for sex-specific methylation marked by DNA methyltransferase expression profiles in mouse germ cells. Dev. Biol. 268:403–415.
   PubMed Web of Science ®Google Scholar
• Li, E., T. H. Bestor, and R. Jaenisch. 1992. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915–926.
   PubMed Web of Science ®Google Scholar
• Lin, R. K., C. H. Hsu, and Y. C. Wang. 2007. Mithramycin A inhibits DNA methyltransferase and metastasis potential of lung cancer cells. Anticancer Drugs 18:1157–1164.
   PubMed Web of Science ®Google Scholar
• Link, P. A., M. R. Baer, S. R. James, D. A. Jones, and A. R. Karpf. 2008. p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia. Cancer Res. 68:9358–9366.
   PubMed Web of Science ®Google Scholar
• Lucarelli, M., A. Fuso, R. Strom, and S. Scarpa. 2001. The dynamics of myogenin site-specific demethylation is strongly correlated with its expression and with muscle differentiation. J. Biol. Chem. 276:7500–7506.
   PubMed Web of Science ®Google Scholar
• Mavis, C. K., S. R. Morey Kinney, B. A. Foster, and A. R. Karpf. 2009. Expression level and DNA methylation status of glutathione S-transferase genes in normal murine prostate and TRAMP tumors. Prostate 69:1312–1324.
   PubMedGoogle Scholar
• McCabe, M. T., J. A. Low, S. Daignault, M. J. Imperiale, K. J. Wojno, and M. L. Day. 2006. Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer. Cancer Res. 66:385–392.
   PubMedGoogle Scholar
• Morey Kinney, S. R., D. J. Smiraglia, S. R. James, M. T. Moser, B. A. Foster, and A. R. Karpf. 2008. Stage-specific alterations of DNA methyltransferase expression, DNA hypermethylation, and DNA hypomethylation during prostate cancer progression in the transgenic adenocarcinoma of mouse prostate model. Mol. Cancer Res. 6:1365–1374.
   PubMed Web of Science ®Google Scholar
• Morey Kinney, S. R., W. Zhang, M. Pascual, J. M. Greally, B. Gillard, E. Karasik, B. A. Foster, and A. R. Karpf. 2009. Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate. Cancer Prevention Res. 2:1065–1075.
   PubMedGoogle Scholar
• Morey, S. R., D. J. Smiraglia, S. R. James, J. Yu, M. T. Moser, B. A. Foster, and A. R. Karpf. 2006. DNA methylation pathway alterations in an autochthonous murine model of prostate cancer. Cancer Res. 66:11659–11667.
   PubMed Web of Science ®Google Scholar
• Nelson, W. G., A. M. De Marzo, and S. Yegnasubramanian. 2009. Epigenetic alterations in human prostate cancers. Endocrinology 150:3991–4002.
   PubMed Web of Science ®Google Scholar
• Oda, M., J. L. Glass, R. F. Thompson, Y. Mo, E. N. Olivier, M. E. Figueroa, R. R. Selzer, T. A. Richmond, X. Zhang, L. Dannenberg, R. D. Green, A. Melnick, E. Hatchwell, E. E. Bouhassira, A. Verma, M. Suzuki, and J. M. Greally. 2009. High-resolution genome-wide cytosine methylation profiling with simultaneous copy number analysis and optimization for limited cell numbers. Nucleic Acids Res. 37:3829–3839.
   PubMed Web of Science ®Google Scholar
• Olsson, L., and J. Forchhammer. 1984. Induction of the metastatic phenotype in a mouse tumor model by 5-azacytidine, and characterization of an antigen associated with metastatic activity. Proc. Natl. Acad. Sci. U. S. A. 81:3389–3393.
   PubMedGoogle Scholar
• Patra, S. K., A. Patra, and R. Dahiya. 2001. Histone deacetylase and DNA methyltransferase in human prostate cancer. Biochem. Biophys. Res. Commun. 287:705–713.
   PubMed Web of Science ®Google Scholar
• Rai, K., L. D. Nadauld, S. Chidester, E. J. Manos, S. R. James, A. R. Karpf, B. R. Cairns, and D. A. Jones. 2006. Zebra fish Dnmt1 and Suv39h1 regulate organ-specific terminal differentiation during development. Mol. Cell. Biol. 26:7077–7085.
   PubMedGoogle Scholar
• Rauch, T., Z. Wang, X. Zhang, X. Zhong, X. Wu, S. K. Lau, K. H. Kernstine, A. D. Riggs, and G. P. Pfeifer. 2007. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc. Natl. Acad. Sci. U. S. A. 104:5527–5532.
   PubMed Web of Science ®Google Scholar
• Robertson, K. D. 2002. DNA methylation and chromatin: unraveling the tangled web. Oncogene 21:5361–5379.
   PubMed Web of Science ®Google Scholar
• Ropke, A., P. Buhtz, M. Bohm, J. Seger, I. Wieland, E. P. Allhoff, and P. F. Wieacker. 2005. Promoter CpG hypermethylation and downregulation of DICE1 expression in prostate cancer. Oncogene 24:6667–6675.
   PubMed Web of Science ®Google Scholar
• Rozen, S., and H. Skaletsky. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132:365–386.
   PubMedGoogle Scholar
• Schenk, T., S. Stengel, S. Goellner, D. Steinbach, and H. P. Saluz. 2007. Hypomethylation of PRAME is responsible for its aberrant overexpression in human malignancies. Genes Chromosomes Cancer 46:796–804.
   PubMedGoogle Scholar
• Schmittgen, T. D., and B. A. Zakrajsek. 2000. Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. J. Biochem. Biophys. Methods 46:69–81.
   PubMedGoogle Scholar
• Shen, L., Y. Kondo, Y. Guo, J. Zhang, L. Zhang, S. Ahmed, J. Shu, X. Chen, R. A. Waterland, and J. P. Issa. 2007. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet. 3:2023–2036.
   PubMed Web of Science ®Google Scholar
• Song, L., S. R. James, L. Kazim, and A. R. Karpf. 2005. Specific method for the determination of genomic DNA methylation by liquid chromatography-electrospray ionization tandem mass spectrometry. Anal. Chem. 77:504–510.
   PubMed Web of Science ®Google Scholar
• Thompson, R. F., M. Reimers, B. Khulan, M. Gissot, T. A. Richmond, Q. Chen, X. Zheng, K. Kim, and J. M. Greally. 2008. An analytical pipeline for genomic representations used for cytosine methylation studies. Bioinformatics 24:1161–1167.
   PubMedGoogle Scholar
• Trinh, B. N., T. I. Long, A. E. Nickel, D. Shibata, and P. W. Laird. 2002. DNA methyltransferase deficiency modifies cancer susceptibility in mice lacking DNA mismatch repair. Mol. Cell. Biol. 22:2906–2917.
   PubMedGoogle Scholar
• Yamada, Y., L. Jackson-Grusby, H. Linhart, A. Meissner, A. Eden, H. Lin, and R. Jaenisch. 2005. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 102:13580–13585.
   PubMed Web of Science ®Google Scholar
• Yaqinuddin, A., S. A. Qureshi, R. Qazi, and F. Abbas. 2008. Down-regulation of DNMT3b in PC3 cells effects locus-specific DNA methylation, and represses cellular growth and migration. Cancer Cell Int. 8:13.
   PubMedGoogle Scholar
• Yaqinuddin, A., S. A. Qureshi, R. Qazi, S. Farooq, and F. Abbas. 2009. DNMT1 silencing affects locus specific DNA methylation and increases prostate cancer derived PC3 cell invasiveness. J. Urol. 182:756–761.
   PubMedGoogle Scholar
• Zorn, C. S., K. J. Wojno, M. T. McCabe, R. Kuefer, J. E. Gschwend, and M. L. Day. 2007. 5-Aza-2′-deoxycytidine delays androgen-independent disease and improves survival in the transgenic adenocarcinoma of the mouse prostate mouse model of prostate cancer. Clin. Cancer Res. 13:2136–2143.
   PubMed Web of Science ®Google Scholar